Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type
Phase 3
Completed
- Conditions
- Mild Cognitive ImpairmentAlzheimer DiseaseCognitive DysfunctionMild DementiaCognitive DeclineDementia, Alzheimer Type
- Interventions
- Device: Renew NCP-5
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2022-05-11
- Lead Sponsor
- Renew Research, LLC
- Target Recruit Count
- 190
- Registration Number
- NCT03721705
- Locations
- 🇺🇸
Irvine Clinical Research, Irvine, California, United States
🇺🇸Charter Research, Lady Lake, Florida, United States
🇺🇸iResearch Savannah, Savannah, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath